S
22
Investments
1
Exits
—
AUM
4.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sciety.
Investment Thesis & Strategy
Sciety invests in various stages of biotech, healthcare, health diagnostics, and home healthcare companies, seeking to support life science innovation.
Investment Activity
Deals per year over the last 4 years
1
20202
20214
20225
2023Portfolio Companies
Selected investments from their portfolio of 22 companies
A
AavantiBio
Biotech · Series B, 2023
A
Alys Pharmaceuticals
Biotech · Series A, 2023
D
Dyno Therapeutics
Biotech · Series A, 2023
A
Aether Bio
Biotech · Series A, 2023
A
A-Alpha Bio
Biotech · Series A, 2023
A
Aera Therapeutics
Biotech · Series A, 2022
E
Enveda Biosciences
Biotech · Series B, 2022
A
Aitia
Biotech · Series B, 2022
R
Replay
Biotech · Series A, 2022
G
Generate Biomedicines
Biotech · Series B, 2021
C
Cellarity
Biotech · Series B, 2021
D
DeepCure
Biotech · Series A, 2020
Frequently Asked Questions
Sciety focuses on Series A, Series B, Series C+ stage investments.